MedPath

Breathing training in the process of rehabilitation after treatment for breast cancer.

Not Applicable
Active, not recruiting
Conditions
Breast cancer
Cancer - Breast
Physical Medicine / Rehabilitation - Physiotherapy
Registration Number
ACTRN12619000473167
Lead Sponsor
Monika Kurzaj
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
61
Inclusion Criteria

Study group (GB):
The study will involve women treated for breast cancer associated in the Wroclaw Femina Fenix Association, regularly participating in general gymnastics since the end of oncological treatment.
The control group consisted of 13 healthy women, never treated for cancer

Exclusion Criteria

- respiratory system diseases
- smoking cigarettes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assesment of inspiratory muscle strength via spirometry by Flowscreen (780, 578, 1.3) Jaeger with a shutter with power unit.[Baseline and after 8 weeks.];Assesment of expiratory muscle strength via spirometry by Flowscreen (780, 578, 1.3) Jaeger with a a shutter with power unit[Baseline and after 8 weeks]
Secondary Outcome Measures
NameTimeMethod
Assesment of lung function via spirometry by Flowscreen (780, 578, 1.3) Jaeger.<br>Parameter:<br>• Vital Capacity (VC) [Baselina and after 8 weeks];Assesment of lung function via spirometry by Flowscreen (780, 578, 1.3) Jaeger.<br>Parameter:<br>• Forced Vital Capacity (FVC) [Baseline and after 8 weeks];Assesment of lung function via spirometry by Flowscreen (780, 578, 1.3) Jaeger.<br>Parameter:<br>• Forced Expiratory Volume in one second (FEV1)[Baseline and after 8 weeks];Assesment of lung function via spirometry by Flowscreen (780, 578, 1.3) Jaeger.<br>Parameter:<br>• Peak Expiratory Flow (PEF) [Baseline and after 8 weeks];Assesment of lung function via spirometry by Flowscreen (780, 578, 1.3) Jaeger.<br>Parameter: <br>•Maximal Expiratory Flow (MEF) [Baseline and after 8 weeks]
© Copyright 2025. All Rights Reserved by MedPath